Showing metabocard for Bacillopeptin B (MMDBc0060739)
Microbial
| Record Information | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Version | 1.0 | ||||||||||||
| Status | Detected and Quantified | ||||||||||||
| Creation Date | 2025-10-02 22:29:33 UTC | ||||||||||||
| Update Date | 2025-10-08 21:35:17 UTC | ||||||||||||
| Metabolite ID | MMDBc0060739 | ||||||||||||
| Metabolite Identification | |||||||||||||
| Common Name | Bacillopeptin B | ||||||||||||
| Description | Bacillopeptin B is a lipopeptide antibiotic produced by the marine sediment-derived bacterium Bacillus amyloliquefaciens SH-B74. This compound features a unique chemical structure characterized by a lipid tail and a cyclic peptide core, which contributes to its antimicrobial properties. The characterization of Bacillopeptin B involves advanced techniques such as NMR spectroscopy and MS/MS spectrometry, which elucidate its molecular composition and structural features (PMID:24064466 ). In terms of biological pathways, Bacillopeptin B is involved in inhibiting the growth of various pathogenic microorganisms, thereby playing a role in the defense mechanisms of the producing organism. The lipopeptide's amphiphilic nature allows it to interact with microbial membranes, disrupting their integrity and leading to cell lysis. This mechanism of action is typical of many lipopeptide antibiotics, which target bacterial cell membranes and interfere with essential cellular processes. Overall, Bacillopeptin B exemplifies the diversity of natural products in microbial secondary metabolism and their potential applications in combating antibiotic-resistant pathogens. | ||||||||||||
| Structure |  | ||||||||||||
| Synonyms | Not Available | ||||||||||||
| Molecular Formula | C47H74N10O16 | ||||||||||||
| Average Mass | 1035.163 | ||||||||||||
| Monoisotopic Mass | 1034.528426343 | ||||||||||||
| IUPAC Name | Not Available | ||||||||||||
| Traditional Name | Not Available | ||||||||||||
| CAS Registry Number | Not Available | ||||||||||||
| SMILES | Not Available | ||||||||||||
| InChI Identifier | Not Available | ||||||||||||
| InChI Key | GVLISDGZEVBRHD-AIDXXVLOSA-N | ||||||||||||
| Chemical Taxonomy | |||||||||||||
| Functional Ontology | |||||||||||||
| Not Available | |||||||||||||
| Physical Properties | |||||||||||||
| State | Not Available | ||||||||||||
| Predicted Properties | Not Available | ||||||||||||
| Spectra | |||||||||||||
| Not Available | |||||||||||||
| Biological Properties | |||||||||||||
| Cellular Locations | Not Available | ||||||||||||
| Biospecimen Locations | Not Available | ||||||||||||
| Tissue Locations | Not Available | ||||||||||||
| Associated OMIM IDs | |||||||||||||
| Human Proteins and Enzymes | |||||||||||||
| |||||||||||||
| Human Pathways | |||||||||||||
| Pathways |
| ||||||||||||
| Microbial Pathways | |||||||||||||
| Pathways | This table shows at most 5 pathways. For the full list of associated pathways: See All Associated Bacterial Pathways
| ||||||||||||
| Metabolic Reactions | |||||||||||||
Reactions This table shows at most 20 reactions. For the full list of associated reactions: See All Associated Reactions
| |||||||||||||
| Health Effects and Bioactivity | |||||||||||||
| |||||||||||||
| Microbial Sources | |||||||||||||
| |||||||||||||
| Exposure Sources | |||||||||||||
| Other Exposures |
| ||||||||||||
| Host Biospecimen and Location | |||||||||||||
| |||||||||||||
| External Links | |||||||||||||
| CMMC Knowledgebase | GVLISDGZEVBRHD-DMKJRJMVSA-N | ||||||||||||
| References | |||||||||||||
| Synthesis Reference | Not Available | ||||||||||||
| General References |
| ||||||||||||
